Net gamma exposure for Exelixis Inc (EXEL) options was positive at the Nov 4, 2026 close, about $1.62M per 1% move in the stock. It has been positive on 19 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for EXEL, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for EXEL, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for EXEL, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
EXEL Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is EXEL gamma exposure positive or negative?
Exelixis net gamma exposure was positive on Nov 4, 2026, at $1.62M. It has been positive on 19 of the last 20 trading days.
How has EXEL gamma exposure changed recently?
Exelixis net gamma exposure went from -$308.22K on Oct 7, 2026 to $1.62M on Nov 4, 2026. See the EXEL gamma exposure history for a longer view.
What is Exelixis Inc?
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer.